71470-41-2 Usage
General Description
ETHYL 4-AMINOPYRIMIDINE-2-CARBOXYLATE is a chemical compound with the molecular formula C8H10N4O2. It is an ethyl ester derivative of 4-aminopyrimidine-2-carboxylic acid and belongs to the class of aminopyrimidine carboxylates. ETHYL 4-AMINOPYRIMIDINE-2-CARBOXYLATE has various industrial and pharmaceutical applications, including its use as an intermediate in the synthesis of pharmaceutical drugs and agrochemicals. It is also used as a building block in the production of organic compounds and is a valuable tool for research and development in the fields of chemistry and pharmacology.ETHYL 4-AMINOPYRIMIDINE-2-CARBOXYLATE is a white to off-white crystalline powder with a melting point of 165-168°C and is soluble in organic solvents such as ethanol, methanol, and dimethyl sulfoxide. It is important to handle this compound with care, as it may cause irritation to the skin, eyes, and respiratory system upon exposure.
Check Digit Verification of cas no
The CAS Registry Mumber 71470-41-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,4,7 and 0 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 71470-41:
(7*7)+(6*1)+(5*4)+(4*7)+(3*0)+(2*4)+(1*1)=112
112 % 10 = 2
So 71470-41-2 is a valid CAS Registry Number.
71470-41-2Relevant articles and documents
Aminopyridyloxypyrazole derivative and preparation method and application thereof
-
Paragraph 0075; 0294; 0296; 0313-0315, (2021/05/19)
The invention relates to an aminopyridyloxypyrazole derivative and a preparation method and application thereof. The structure of the aminopyridyloxypyrazole derivative is shown as a formula (I). The invention provides a brand-new aminopyridyloxypyrazole derivative which has obvious effects of inhibiting TGF [beta] R1 (ALK5) kinase activity and treating cancer or fibrosis related diseases, and the preparation method of the derivative is simple and easy to operate.
Amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutical compositions thereof
-
, (2008/06/13)
The invention relates to novel amino or acylamino-substituted pyrimidinyl cephalosporanic acid derivatives and pharmaceutically acceptable salts thereof, of antibacterial activity, to processes for the preparation thereof, and to pharmaceutical compositio